185 related articles for article (PubMed ID: 34894610)
1. Morphinan derivatives with an oxabicyclo[3.2.1]octane structure as dual agonists toward δ and κ opioid receptors.
Uenohara Y; Tsumura S; Hirayama S; Higashi E; Watanabe Y; Gouda H; Nagase H; Fujii H
Bioorg Med Chem; 2022 Jan; 53():116552. PubMed ID: 34894610
[TBL] [Abstract][Full Text] [Related]
2. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
[TBL] [Abstract][Full Text] [Related]
3. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of quinolinomorphinan-4-ol derivatives as δ opioid receptor agonists.
Ida Y; Nemoto T; Hirayama S; Fujii H; Osa Y; Imai M; Nakamura T; Kanemasa T; Kato A; Nagase H
Bioorg Med Chem; 2012 Jan; 20(2):949-61. PubMed ID: 22197670
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Peripheral κ-Opioid Receptor Agonists as Novel Analgesics.
Suzuki S; Sugawara Y; Inada H; Tsuji R; Inoue A; Tanimura R; Shimozono R; Konno M; Ohyama T; Higashi E; Sakai C; Kawai K
Chem Pharm Bull (Tokyo); 2017; 65(11):1085-1088. PubMed ID: 29093296
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure-Activity Relationship Study on Nalfurafine Analogues.
Li M; Stevens DL; Arriaga M; Townsend EA; Mendez RE; Blajkevch NA; Selley DE; Banks ML; Negus SS; Dewey WL; Zhang Y
ACS Chem Neurosci; 2022 Dec; 13(24):3608-3628. PubMed ID: 36449691
[TBL] [Abstract][Full Text] [Related]
7. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB
Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348
[TBL] [Abstract][Full Text] [Related]
8.
Kong L; Shu X; Tang S; Ye R; Sun H; Jiang S; Li Z; Chai J; Fang Y; Lan Y; Yu L; Xie Q; Fu W; Wang Y; Li W; Qiu Z; Liu J; Shao L
J Med Chem; 2022 Aug; 65(15):10377-10392. PubMed ID: 35900351
[TBL] [Abstract][Full Text] [Related]
9. The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, δ opioid receptor agonists.
Nemoto T; Ida Y; Iihara Y; Nakajima R; Hirayama S; Iwai T; Fujii H; Nagase H
Bioorg Med Chem; 2013 Dec; 21(24):7628-47. PubMed ID: 24262888
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies.
Nemoto T; Yamamoto N; Watanabe A; Fujii H; Hasebe K; Nakajima M; Mochizuki H; Nagase H
Bioorg Med Chem; 2011 Feb; 19(3):1205-21. PubMed ID: 21256034
[TBL] [Abstract][Full Text] [Related]
12. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.
Li G; Aschenbach LC; Chen J; Cassidy MP; Stevens DL; Gabra BH; Selley DE; Dewey WL; Westkaemper RB; Zhang Y
J Med Chem; 2009 Mar; 52(5):1416-27. PubMed ID: 19199782
[TBL] [Abstract][Full Text] [Related]
14. Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.
Nagase H; Watanabe A; Nemoto T; Yamaotsu N; Hayashida K; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Hirono S; Fujii H
Bioorg Med Chem Lett; 2010 Jan; 20(1):121-4. PubMed ID: 19962305
[TBL] [Abstract][Full Text] [Related]
15. Allosterism within
Jacobs BA; Pando MM; Jennings E; Chavera TA; Clarke WP; Berg KA
Mol Pharmacol; 2018 Apr; 93(4):376-386. PubMed ID: 29436492
[TBL] [Abstract][Full Text] [Related]
16. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
Ko MC; Husbands SM
J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of quinolinomorphinan derivatives as highly selective δ opioid receptor ligands.
Ida Y; Matsubara A; Nemoto T; Saito M; Hirayama S; Fujii H; Nagase H
Bioorg Med Chem; 2012 Oct; 20(19):5810-31. PubMed ID: 22967810
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.
Kaski SW; White AN; Gross JD; Trexler KR; Wix K; Harland AA; Prisinzano TE; Aubé J; Kinsey SG; Kenakin T; Siderovski DP; Setola V
J Pharmacol Exp Ther; 2019 Nov; 371(2):487-499. PubMed ID: 31492823
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
Nakajima R; Yamamoto N; Hirayama S; Iwai T; Saitoh A; Nagumo Y; Fujii H; Nagase H
Bioorg Med Chem; 2015 Oct; 23(19):6271-9. PubMed ID: 26346669
[TBL] [Abstract][Full Text] [Related]
20. Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities.
Hayashida K; Hirayama S; Iwai T; Watanabe Y; Takahashi T; Sakai J; Nakata E; Yamakawa T; Fujii H; Nagase H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2742-2745. PubMed ID: 28522254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
